Verum.de Offers Presentation on Advantages of Running Clinical Trials in Central Eastern Europe at International Pharma Conferences in China

Verum.de, a full-clinical service, German-based contract research organization (CRO) with seven offices throughout Europe and a U.S. office in Carlsbad, Calif., will participate in two upcoming conferences in China: The Sino-Euro-Bio-Partnering (SEBP) in Shanghai, May 29th, and the 15th Shanghai International Forum on Biotechnology & Pharmaceutical Industry, May 30-31, 2013.

Dagmar Siebold, European Director of Client Relations, will present a lecture on Verum’s clinical research expertise and ability to run trials based on Western standards at the invitation only Bio-cluster workshop at the SEBP conference at 1:30 p.m. CST, Wed., May 29, 2013. The workshop topics include how to establish a strategic cluster alliance between China and Europe and how to help manufacturers go international. The workshop is sponsored by the European Union “BioXclusters Project” and brings together four leading European biotech and healthcare clusters under the coordination of Entreprise Rhône-Alpes International (ERAI).

“We look forward to having a dialogue with Chinese biopharma companies and technology parks to exchange ideas about partnerships for reciprocal clinical trial services between China and Central Eastern Europe,” said Christian Sacher, Verum.de CEO. “China’s technology advancement is fast-paced. We can support Chinese sponsors as well as Chinese CROs looking for European market approval by helping them to conduct more affordable and fast recruiting clinical trials in CEE and CIS.”

Verum.de will be setting meetings with Chinese pharma and biotech companies May 27-28, 2013. Those interested in setting appointments to learn more about Verum.de can email Dagmar Siebold at ds@verum.de or call T +49 (089) 800 777 64.

About Verum.de

Verum has been the first Western-Standard CRO specializing in CEE/CIS countries, key competence is Full Clinical Service for Phase II-IV. Verum has successfully completed more than 130 Clinical Trials with about 40,000 patients for pharma, biotech and medical device companies as well as the US NIH. The company’s expertise covers cardiovascular, neurology, psychiatry, CNS, pain, oncology, and more. Operating since 1992, Verum is the strongest player in high recruiting CEE areas and maintains offices all over Eastern Europe, Germany and the US.

More information can be found at http://www.verum.de